pha3thb pharmacy practice and therapeutics b (metabolic and endocrine)

PHARMACY PRACTICE AND THERAPEUTICS B (METABOLIC AND ENDOCRINE)

PHA3THB

2020

Credit points: 15

Subject outline

This subject will integrate the teaching of pharmacology, medicinal chemistry and pharmacy practice relating to the use of drugs for gastroenterology, hepatic, reproductive and endocrine disorders. Students will initially explore the mechanism of action of these drugs, specifically how they affect biochemical and physiological processes at the cellular and organ level, and then relate this to the overall clinical effect on the individual. The medicinal chemistry of these drugs will then be explored so that structure-function relationships can be determined at the molecular level. Finally, the pharmacy practice issues relating to these conditions and medications will be addressed, in a manner that highlights how these drugs can ameliorate the various disease states, and affect the overall clinical condition of the patient.

SchoolMolecular Sciences

Credit points15

Subject Co-ordinatorNick Standen

Available to Study Abroad/Exchange StudentsYes

Subject year levelYear Level 3 - UG

Exchange StudentsNo

Available as ElectiveNo

Learning ActivitiesN/A

Capstone subjectNo

Subject particulars

Subject rules

Prerequisites PHA2THA and must be admitted into the Bachelor of Pharmacy course (SHPB)

Co-requisitesN/A

Incompatible subjectsN/A

Equivalent subjectsPHA3PGC

Quota Management StrategyN/A

Quota-conditions or rulesN/A

Special conditionsN/A

Minimum credit point requirementN/A

Assumed knowledgeN/A

Learning resources

An Introduction to Medicinal Chemistry

Resource TypeBook

Resource RequirementRecommended

AuthorPatrick, G

Year2009

Edition/Volume4TH ED

PublisherOXFORD, NEW YORK

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Goodman & Gilman's Manual of Pharmacology and Therapeutics

Resource TypeBook

Resource RequirementPrescribed

AuthorBrunton, L, Knollman B, & Hilal-Dandan R

Year2013

Edition/Volumesoft cover portable volume 10TH ED

PublisherMCGRAW-HILL

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Therapeutic Guidelines: Gastrointestinal. Version 4

Resource TypeBook

Resource RequirementRecommended

AuthorTherapeutic Guidelines Ltd

Year2006

Edition/VolumeN/A

PublisherTHERAPEUTIC GUIDELINES LIMITED, MELBOURNE

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Therapeutic Guidelines: Endocrinology. Version 5

Resource TypeBook

Resource RequirementRecommended

AuthorTherapeutic Guidelines Ltd. Expert Writing Group

Year2011

Edition/VolumeN/A

PublisherTHERAPEUTIC GUIDELINES LTD, MELBOURNE.

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Clinical Pharmacy and Therapeutics

Resource TypeBook

Resource RequirementRecommended

AuthorWalker R & Whittlesea C Eds

Year2011

Edition/Volume5TH ED

PublisherEDINBURGH: CHURCHILL LIVINGSTONE

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Pharmacology

Resource TypeBook

Resource RequirementRecommended

AuthorRang HP, Dale MM, Ritter JM and Moore PK

Year2016

Edition/Volume8TH ED

PublisherCHURCHILL LIVINGSTONE, EDINBURGH

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Career Ready

Career-focusedNo

Work-based learningNo

Self sourced or Uni sourcedN/A

Entire subject or partial subjectN/A

Total hours/days requiredN/A

Location of WBL activity (region)N/A

WBL addtional requirementsN/A

Graduate capabilities & intended learning outcomes

Graduate Capabilities

Intended Learning Outcomes

01. Explain the pathophysiology for a selection of disease states associated with the endocrine system, reproductive system and body metabolism.

02. Relate the relevant class of drugs to activity at the molecular level, specifically, effect on relevant receptors and other regulatory molecules and processes.

03. Describe and explain the relationship between drug actions and therapeutic outcomes, specifically in the amelioration of disease states associated with the endocrine system or body metabolism.

04. Describe the absorption, elimination and metabolism of endocrine and gastrointestinal drugs and relate this to clinical practice and how pharmacogenetics affects this.

05. Anticipate and rationalize interaction between drugs(including over-the-counter (OTC and other substances)

06. Follow guidelines to critically assess drug use and disease states in a defined case study scenario.

07. Discuss alterations in human metabolism as a consequence of altered liver function.

Subject options

Select to view your study options…

Bendigo, 2020, Semester 1, Day

Overview

Online enrolmentYes

Maximum enrolment sizeN/A

Enrolment informationN/A

Subject Instance Co-ordinatorRichard Summers

Class requirements

LectureWeek: 10 - 22
Three 1.00 hour lecture per week on weekdays during the day from week 10 to week 22 and delivered via face-to-face.

TutorialWeek: 13 - 22
Six 1.00 hour tutorial per study period on weekdays during the day from week 13 to week 22 and delivered via face-to-face.

WorkShopWeek: 11 - 22
One 2.00 hours workshop per week on weekdays during the day from week 11 to week 22 and delivered via face-to-face.

Assessments

Assessment element	Comments	Category	Contribution	Hurdle	%	ILO*
2 x case studies (1000 words equiv. in total)	N/A	N/A	N/A	No	40	SILO1, SILO2, SILO3, SILO6, SILO7
One 2-hour examination	N/A	N/A	N/A	No	50	SILO1, SILO2, SILO3, SILO4, SILO5, SILO6, SILO7
Mid-semester test (1 hour) (1000 words equiv)	N/A	N/A	N/A	No	10	SILO1, SILO2, SILO3, SILO4, SILO5, SILO6, SILO7